25th Sep 2013 16:41
Heavy falls from Carnival, Tesco and utility stocks weighed on the FTSE 100 on Wednesday while uncertainty over the US budget and Federal Reserve monetary policy continued to dampen sentiment. London's benchmark index finished 19.93 points lower at 6,551.53, a fall of 0.3% on the day. This was the
Read more25th Sep 2013 09:46
Amec: JP Morgan reduces target price from 1301p to 1243p and stays with its neutral rating. Amlin: UBS ups target price from 400p to 450p upgrading from neutral to buy. BAE Systems: UBS takes target price from 450p to 490p and maintains a buy recommendation. BHP Billiton: Alphavalue shifts target
Read more18th Sep 2013 08:28
African Minerals: Canaccord Genuity reduces target price from 410p to 330p, while its buy recommendation remains unaltered. Amlin: Goldman Sachs moves target price from 405p to 420p and reiterates a neutral rating. Andor Technology: Investec takes target price from 360p to 410p leaving its buy rec
Read more28th Aug 2013 15:59
CareTech, the AIM-listed social care services firm, announced Wednesday that both its Executive Chairman and Chief Executive Officer each purchased 485,000 shares. Farouq Sheikh and Haroon Sheikh both paid 190p a share, costing a total of £921,500. The purchases were announced the same day the c
Read more19th Aug 2013 07:17
First-half profits were trimmed at specialist insurer Amlin due to lower contribution from investments and pressure on catastrophe reinsurance rates. But management sees a number of encouraging trends and insists there remains good margin potential for the FTSE 250 group, despite the 12.5% fall in
Read more14th Jun 2013 08:15
Amlin: UBS starts with a target price of 400p and a neutral rating. Cairn Energy: JP Morgan takes target price from 320p to 340p maintaining a neutral rating. Catlin: UBS initiates with a target price of 475p and a neutral rating. Chemring: Credit Suisse increases target price from 210p to 260p a
Read more30th May 2013 08:19
AMEC: Morgan Stanley reduces target price from 1220p to 1100p and retains an underweight rating. Amlin: JP Morgan takes target price from 360p to 400p maintaining an underweight rating. Brewin Dolphin: Canaccord Genuity raises target price from 230p to 285p and reiterates a buy recommendation. C
Read more22nd May 2013 09:37
Afferro Mining: Panmure Gordon reduces target price from 279p to 100p, while keeping its buy recommendation. Amara Mining: Westhouse Securities cuts target price from 110p to 90p retaining a buy recommendation. Amlin: Westhouse Securities moves target price from 455p to 470p and upgrades to add.
Read more20th May 2013 08:32
Alent: Credit Suisse initiates with a target price of 430p and an outperform rating. Amlin: Morgan Stanley ups target price from 428p to 469p, while maintaining an overweight rating. Anite: Espirito Santo cuts target price from 180p to 165p retaining a buy recommendation. Ashtead Group: UBS takes
Read more16th May 2013 11:50
Non-life insurance company Amlin has said it had a good start to 2013, with 'healthy' rate increases across a number of key classes underwritten by the group. The firm also reported catastrophe and large loss activity was benign, and a higher-than-expected return on investment was achieved at 1.8%
Read more10th Apr 2013 16:27
John Whybrow, the Chairman of AZ Electronic Materials, which on Tuesday tanked after it issued a warning on full year revenue, has shown his faith in the chemicals company by enlarging his shareholding. Whybrow acquired 40,000 shares at 254p each for a total trade value of £101,600, taking his sta
Read more12th Mar 2013 07:19
Abcam:Investec shifts target price from 484p to 487p and keeps a buy recommendation. Admiral Group: UBS ups target price from 1200p to 1275p and reiterates a neutral rating. Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral. Anite: Numis reduce
Read more11th Mar 2013 07:23
Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling. Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral. Anite Group: Invetsec downgrades from buy to hold with a target price of 157p. Aviva: Citigroup reduc
Read more6th Mar 2013 07:03
Advanced Medical Solutions: Investec takes target price from 68p to 74p and maintains a buy recommendation. Aggreko: Citigroup reduces target price from 2550p to 2100p, while keeping a buy rating. Ashtead Group: Citigroup raises target price from 590p to 660p leaving its buy recommendation unalter
Read more5th Mar 2013 07:29
Oil explorer Ithaca Energy was off a touch on Monday, after having taken a hit on Friday, when it announced the purchase of Valiant Petroleum. While some nerves may be understandable the oil team at Westhouse Securities points out that the fact the deal could pay for itself in two years may have bee
Read more